Zhang X - Search Results

1

Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy.

Ravirala D, Mistretta B, Gunaratne PH, Pei G, Zhao Z, Zhang X. Ravirala D, et al. Among authors: zhang x. J Immunother Cancer. 2021 Jul;9(7):e002454. doi: 10.1136/jitc-2021-002454. J Immunother Cancer. 2021. PMID: 34230110 Free PMC article.

2

Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing.

Ravirala D, Pei G, Zhao Z, Zhang X. Ravirala D, et al. Among authors: zhang x. Cancer Immunol Immunother. 2022 Jun;71(6):1479-1495. doi: 10.1007/s00262-021-03084-2. Epub 2021 Oct 30. Cancer Immunol Immunother. 2022. PMID: 34716463 Free PMC article.

3

Single-cell RNA sequencing reveals a strong connection between Gadd45g upregulation and oncolytic HSV infection in tumor tissue.

Ravirala D, Pei G, Zhao Z, Zhang X. Ravirala D, et al. Among authors: zhang x. Mol Ther Oncolytics. 2021 Oct 20;23:330-341. doi: 10.1016/j.omto.2021.10.006. eCollection 2021 Dec 17. Mol Ther Oncolytics. 2021. PMID: 34786476 Free PMC article.

4

Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication.

Fu X, Tao L, Rivera A, Zhang X. Fu X, et al. Among authors: zhang x. Int J Cancer. 2011 Sep 15;129(6):1503-10. doi: 10.1002/ijc.25808. Epub 2011 Feb 26. Int J Cancer. 2011. PMID: 21128236 Free PMC article.

5

Coadministration of a herpes simplex virus-2 based oncolytic virus and cyclophosphamide produces a synergistic antitumor effect and enhances tumor-specific immune responses.

Li H, Zeng Z, Fu X, Zhang X. Li H, et al. Among authors: zhang x. Cancer Res. 2007 Aug 15;67(16):7850-5. doi: 10.1158/0008-5472.CAN-07-1087. Cancer Res. 2007. PMID: 17699791

6

Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.

Li H, Dutuor A, Tao L, Fu X, Zhang X. Li H, et al. Among authors: zhang x. Clin Cancer Res. 2007 Jan 1;13(1):316-22. doi: 10.1158/1078-0432.CCR-06-1625. Clin Cancer Res. 2007. PMID: 17200370

7

An HSV-2 based oncolytic virus can function as an attractant to guide migration of adoptively transferred T cells to tumor sites.

Fu X, Rivera A, Tao L, Zhang X. Fu X, et al. Among authors: zhang x. Oncotarget. 2015 Jan 20;6(2):902-14. doi: 10.18632/oncotarget.2817. Oncotarget. 2015. PMID: 25460506 Free PMC article.

8

Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.

Fu X, Rivera A, Tao L, Zhang X. Fu X, et al. Among authors: zhang x. Mol Ther. 2012 Oct;20(10):1871-81. doi: 10.1038/mt.2012.113. Epub 2012 Jun 12. Mol Ther. 2012. PMID: 22692498 Free PMC article.

9

Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells.

Fu X, Rivera A, Tao L, De Geest B, Zhang X. Fu X, et al. Among authors: zhang x. Mol Ther. 2012 Feb;20(2):339-46. doi: 10.1038/mt.2011.265. Epub 2011 Dec 6. Mol Ther. 2012. PMID: 22146341 Free PMC article.

10

Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles.

Fu X, Tao L, Wang PY, Cripe TP, Zhang X. Fu X, et al. Among authors: zhang x. Oncotarget. 2018 Apr 20;9(30):21348-21358. doi: 10.18632/oncotarget.25096. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765544 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183,137 results

Search Page

Filters